Diovan Related Clinical Trials
ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria [Completed]
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM [Recruiting]
To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone [Completed]
Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension [Recruiting]
Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers [Completed]
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease [Terminated]
Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications [Completed]
Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg [Completed]
Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg [Completed]
Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients [Not yet recruiting]
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers [Completed]
TAK-491 (Azilsartan Medoxomil) Compared to Valsartan in Chinese Participants With Hypertension [Not yet recruiting]
Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan [Completed]
Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study [Active, not recruiting]
Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301) [Completed]
Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy [Completed]
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses) [Completed]
The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial) [Terminated]
Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study) [Completed]
Effect of Valsartan on Carotid Artery Disease [Completed]
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide [Completed]
Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose [Completed]
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus [Completed]
Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD [Recruiting]
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy [Completed]
Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension [Completed]
Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke [Recruiting]
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension. [Completed]
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects [Completed]
Pharmacokinetic Study of Livalo� Fixed Combination Drug in Healthy Subjects [Not yet recruiting]
Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension [Completed]
The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction [Completed]
Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension [Completed]
Regression of Fatty Heart by Valsartan Therapy [Recruiting]
Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension [Completed]
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease [Completed]
The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome [Withdrawn]
Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics [Active, not recruiting]
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension [Completed]
A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan [Not yet recruiting]
An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension. [Completed]
Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension [Completed]
Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol [Active, not recruiting]
Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension [Completed]
Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension [Completed]
Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia [Completed]
8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension [Completed]
Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension [Completed]
Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension [Completed]
Valsartan Intensified Primary Care Reduction of Blood Pressure Study [Completed]
A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension [Completed]
Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome [Completed]
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension [Completed]
Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients [Completed]
Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients [Completed]
Pharmacokinetic Study of Livalo� Fixed Combination Drug in Healthy Subjects [Completed]
Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension [Completed]
Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure [Completed]
Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise [Completed]
Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus [Completed]
Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients [Completed]
Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects. [Completed]
An Open Label Extension Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension [Completed]
Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects. [Completed]
Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy [Recruiting]
Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension [Completed]
Efficacy and Safety of LCZ696A in Patients With Essential Hypertension [Completed]
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension [Completed]
Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients [Completed]
Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients. [Completed]
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide. [Completed]
Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults [Completed]
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension [Completed]
The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy [Completed]
Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients [Completed]
Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease [Not yet recruiting]
A Drug Interaction Study of Cilnidipine and Valsartan [Completed]
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide [Completed]
Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101) [Completed]
Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent [Completed]
Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions [Completed]
The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling [Recruiting]
Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions [Completed]
Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome [Completed]
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction [Completed]
GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence [Completed]
Fimasartan Achieving SBP Target (FAST) Study [Recruiting]
Antiproteinuric Effect of Valsartan and Lisinopril [Completed]
Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension [Completed]
The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria [Not yet recruiting]
Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168) [Terminated]
A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure [Completed]
|